Verona Pharma plc (VRP.L) (LON:VRP) Stock Crosses Below 200 Day Moving Average – Should You Sell?

Verona Pharma plc (VRP.L) (LON:VRP) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 55 ($0.69) and traded as low as GBX 50 ($0.63). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.69), with a volume of 70,791 shares.

Verona Pharma plc (VRP.L) Price Performance

The firm’s fifty day moving average is GBX 55 and its 200 day moving average is GBX 55. The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99. The firm has a market cap of £228 million and a P/E ratio of -1.68.

Verona Pharma plc (VRP.L) Company Profile

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.